Erlotinib as an alternative treatment for NSCLC. Case Report
{{output}}
Introduction: Erlotinib is an approved treatment for NSCLC locally advanced or with metastases, after failure of initial chemotherapy. The authors present a NSCLC clinical case of great clinical and imaging improvement, with no d... ...